Singapore, Jan. 21, 2026 (GLOBE NEWSWIRE) -- In a major step forward for AI-driven business solutions, Simplex AI today announced it has secured $6 million in funding from GL Ventures to accelerate the launch of Lev8, its flagship real- time people intelligence platform. Designed to help sales teams, recruiters, founders and inverstors discover high-value prospects at the right moment, Lev8 turns the open web into a live, actionable intelligence engine—redefining how modern teams identify and connect with d ...

Core Insights - The Invesco WilderHill Clean Energy ETF (NYSEARCA:PBW) has experienced a significant increase in share price, climbing 74% over the past year, from approximately $20 to $35 [1] Company Performance - The ETF's share price growth indicates strong investor interest and confidence in clean energy investments [1]

The rapid build-out of artificial intelligence infrastructure by U.S. tech firms such as OpenAI, Alphabet-owned Google and Microsoft has absorbed much of the world's memory chip supply, pushing up prices as manufacturers prioritize components for higher-margin data centers over consumer devices.Samsung, SK Hynix and Micron, the world's three largest producers of memory ‌chips, have said in recent ‌months that they were struggling to keep up with demand as they reported rosy quarterly earnings on the back of ...

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! AI is eating the world—and the machines behind it are ravenous. Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink. Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and b ...

Sen. Elizabeth Warren (D-Mass.) slammed Treasury Secretary Scott Bessent for downplaying the risks of waning global demand for U.S. Treasuries.It’s A ‘Huge Deal’On Wednesday, in a post on X, Warren criticized Bessent’s comments during the World Economic Forum at Davos, when he said that he was “not concerned at all” about investors selling American Treasuries.“It's a huge deal,” Warren said, warning that because Treasuries are seen as the benchmark for the financial system, weaker demand could translate int ...

Core Insights - Wealthfront Corporation has experienced a significant decline in its stock price following its first post-IPO earnings release, attributed to disappointing asset flow figures and investor concerns regarding its mortgage business strategy [5][6]. Group 1: Company Performance - Wealthfront's stock price fell from $14.00 at its IPO on December 12, 2025, to $10.26 by January 14, 2026, representing a decrease of $3.74 or 26.71% [6]. - The company reported softer net inflows in recent months, indicating a slowdown in client acquisitions and cash management balances compared to previous periods [5]. Group 2: Investor Concerns - There is heightened market scrutiny regarding the CEO's ownership stake in a banking partner that is central to Wealthfront's mortgage initiative, raising concerns about potential conflicts of interest and long-term integration risks [5]. - The decline in stock price and emerging investor concerns have led to calls for potential legal claims against the company for those who suffered significant losses [2][5].

Core Viewpoint - Oil prices increased on Thursday following the U.S. president's decision to retract threats of tariffs related to the acquisition of Greenland, which mitigated the risk of a U.S.–Europe trade war and provided support for the oil market [1] Group 1 - The U.S. president's actions have reduced tensions that could have escalated into a trade conflict with Europe, positively impacting oil prices [1] - The easing of trade war threats is seen as a stabilizing factor for the oil market, contributing to the upward movement in prices [1]

Core Viewpoint - BitGo Holdings, Inc. has announced the pricing of its initial public offering (IPO) at $18.00 per share for a total of 11,821,595 shares of Class A common stock [1] Group 1: IPO Details - The IPO consists of 11,026,365 shares of Class A common stock being offered by BitGo and 795,230 shares being offered by existing stockholders [1] - BitGo will not receive any proceeds from the shares sold by existing stockholders [1]

Core Insights - Allka Research has over two decades of experience in investment, focusing on uncovering undervalued assets in ETFs, commodities, technology, and pharmaceuticals [1] - The company emphasizes a conservative investment approach, aiming to deliver substantial returns and strategic insights to clients [1] - Allka Research is committed to simplifying investment strategies, making them accessible to both seasoned and novice investors [1] Company Mission - The mission of Allka Research is to empower individuals financially by sharing knowledge and insights through Seeking Alpha [1] - The company aims to provide thought-provoking analyses and informed perspectives to foster a community of informed investors [1] - Allka Research seeks to demystify investing, inspiring confidence in readers to navigate the markets intelligently [1]

Core Viewpoint - Johnson & Johnson is navigating tariff challenges by negotiating price reductions in exchange for tariff exemptions, which could enhance sales volume despite lower prices [3][4][5]. Group 1: Financial Performance - Johnson & Johnson reported a net income of over $14 billion as of 2024, with a revenue increase of 6.8% year over year to $24 billion in the third quarter [5][7]. - The adjusted earnings per share for the company reached $2.8, reflecting a 15.7% increase compared to the previous year [7]. - The company has a market capitalization of $526 billion, with a gross margin of 68.27% and a dividend yield of 2.36% [7]. Group 2: Tariff and Manufacturing Strategy - Johnson & Johnson has 64 manufacturing facilities, with 41 located outside the U.S., making it susceptible to tariff impacts [4]. - The company estimated $400 million in tariff-related costs for fiscal year 2025 prior to recent developments [4]. - The tariff exemption deal allows Johnson & Johnson to avoid higher costs from import duties while potentially increasing sales volume [3][5]. Group 3: Product Portfolio and Innovation - The company has a diversified product portfolio, including cancer drugs like Darzalex and Erleada, and immunosuppressant Tremfya, which have compensated for the loss of patent exclusivity for Stelara [7][8]. - Johnson & Johnson has a robust product pipeline with new approvals such as Imaavy for generalized myasthenia gravis and Akeega for prostate cancer [9]. - The company is also developing the Ottava system within its medtech division to enter the robotic surgery market [10]. Group 4: Long-term Outlook - Johnson & Johnson is considered a strong buy-and-hold option, particularly for dividend investors, as it is a Dividend King with over 50 consecutive years of payout increases [11]. - The aging global population presents long-term growth opportunities for the company, as seniors require more medical care and pharmaceutical products [10].